Latest filing published 16 Nov 2021 for 博济医药, €364k.
Filing timeline
BuySaleInsider track record
王廷春: trading record in brief
王廷春 is a declared insider of 博济医药 (chief executive), with filings sourced from SSE / SZSE (CSRC). In total, 4 filings cover trades dated from 14 September 2021 to 16 November 2021.
Every open-market trade on record is a sale: 4 sales worth €2.2M.
Most recently, on 16 November 2021, the filings show an open-market sale worth €364k in 博济医药. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 王廷春
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 189,500 shares16.8% of flowA股XSHESZSE:173000009858838620
- 288,600 shares24.2% of flowA股XSHESZSE:173000005073039400
- 353,600 shares28.9% of flowA股XSHESZSE:173000005073039360
- 557,000 shares30.2% of flowA股XSHESZSE:173000004826263400
4 of 4 declarations